{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:08:56Z","timestamp":1790352536549,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["MOST 111-2314-B-650-002-MY3"],"award-info":[{"award-number":["MOST 111-2314-B-650-002-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC112-2320-B-038-021, and NSTC112-2314-B-038-005"],"award-info":[{"award-number":["NSTC112-2320-B-038-021, and NSTC112-2314-B-038-005"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC113-2314-B-038-069, NSTC114-2637-B-038-004, and NSTC112-2314-B 038-004"],"award-info":[{"award-number":["NSTC113-2314-B-038-069, NSTC114-2637-B-038-004, and NSTC112-2314-B 038-004"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","award":["DP2-107-20000"],"award-info":[{"award-number":["DP2-107-20000"]}],"id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003835","name":"I-Shou University","doi-asserted-by":"publisher","award":["EDPJ 111064, EDAHJ 112005, EDAHJ 113017"],"award-info":[{"award-number":["EDPJ 111064, EDAHJ 112005, EDAHJ 113017"]}],"id":[{"id":"10.13039\/501100003835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003835","name":"I-Shou University","doi-asserted-by":"publisher","award":["EDAHS113034"],"award-info":[{"award-number":["EDAHS113034"]}],"id":[{"id":"10.13039\/501100003835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003835","name":"I-Shou University","doi-asserted-by":"publisher","award":["EDAHS114030"],"award-info":[{"award-number":["EDAHS114030"]}],"id":[{"id":"10.13039\/501100003835","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07865-0","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T02:45:14Z","timestamp":1772073914000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Integrin \u03b1v\u03b23-dependent pathogenic effect and therapeutic effects of DL-N2 combined with EGFR inhibitors in pancreatic adenocarcinoma"],"prefix":"10.1186","volume":"24","author":[{"given":"Zi-Lin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"San-Nan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tung-Cheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Chung","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Ning","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Jung","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana R.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Gionfra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahlak Daniel","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Kuo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Thi Minh","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ru","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amruta","family":"Aher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandana Bayu","family":"Abhista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Jung","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Yang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haw-Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Yun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaqueline","family":"Whang-Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"7865_CR1","doi-asserted-by":"crossref","unstructured":"Biniyazova A et al. The Incidence, Mortality, and survival trends of pancreatic cancer in kazakhstan: data from the National electronic registry of oncological patients (2014\u20132023). Cancers (Basel). 2025;17(14).","DOI":"10.3390\/cancers17142277"},{"key":"7865_CR2","doi-asserted-by":"crossref","unstructured":"Lee HA, Chen KW, Hsu CY. Prediction model for pancreatic cancer-a population-based study from NHIRD. Cancers (Basel). 2022;14(4).","DOI":"10.3390\/cancers14040882"},{"key":"7865_CR3","doi-asserted-by":"crossref","unstructured":"Lin Z et al. Early detection of pancreatic cancer: current advances and future opportunities. Biomedicines. 2025;13(7).","DOI":"10.3390\/biomedicines13071733"},{"issue":"2","key":"7865_CR4","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.3390\/cancers3021513","volume":"3","author":"M Oliveira-Cunha","year":"2011","unstructured":"Oliveira-Cunha M, Newman WG, Siriwardena AK. Epidermal growth factor receptor in pancreatic cancer. Cancers (Basel). 2011;3(2):1513\u201326.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"7865_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jcmgh.2020.08.004","volume":"11","author":"RC Turaga","year":"2021","unstructured":"Turaga RC, et al. Modulation of cancer-Associated fibrotic stroma by an integrin \u03b1(v)\u03b2(3) targeting protein for pancreatic cancer treatment. Cell Mol Gastroenterol Hepatol. 2021;11(1):161\u201379.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"1","key":"7865_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12929-021-00719-5","volume":"28","author":"YSH Yang","year":"2021","unstructured":"Yang YSH, et al. Role of thyroid hormone-integrin \u03b1v\u03b23-signal and therapeutic strategies in colorectal cancers. J Biomed Sci. 2021;28(1):24.","journal-title":"J Biomed Sci"},{"issue":"3","key":"7865_CR7","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/carcin\/21.3.427","volume":"21","author":"BE Henderson","year":"2000","unstructured":"Henderson BE, Feigelson HS. Hormonal carcinogenesis. Carcinogenesis. 2000;21(3):427\u201333.","journal-title":"Carcinogenesis"},{"issue":"12","key":"7865_CR8","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1089\/thy.2019.0413","volume":"29","author":"KA Schmohl","year":"2019","unstructured":"Schmohl KA, et al. Integrin \u03b1v\u03b23-Mediated effects of thyroid hormones on mesenchymal stem cells in tumor angiogenesis. Thyroid. 2019;29(12):1843\u201357.","journal-title":"Thyroid"},{"issue":"3","key":"7865_CR9","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1002\/j.2040-4603.2016.tb00712.x","volume":"6","author":"HY Lin","year":"2016","unstructured":"Lin HY, et al. Thyroid Hormone, Cancer, and apoptosis. Compr Physiol. 2016;6(3):1221\u201337.","journal-title":"Compr Physiol"},{"key":"7865_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3389\/fphar.2020.00095","volume":"11","author":"M Debreli Coskun","year":"2020","unstructured":"Debreli Coskun M, et al. \u03b1v\u03b23 integrin antagonists enhance chemotherapy response in an orthotopic pancreatic cancer model. Front Pharmacol. 2020;11:95.","journal-title":"Front Pharmacol"},{"issue":"1","key":"7865_CR11","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s13046-021-01946-2","volume":"40","author":"M Kemper","year":"2021","unstructured":"Kemper M, et al. Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression. J Exp Clin Cancer Res. 2021;40(1):214.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"7865_CR12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/ncb2953","volume":"16","author":"L Seguin","year":"2014","unstructured":"Seguin L, et al. An integrin \u03b2\u2083-KRAS-RalB complex drives tumour stemness and resistance to EGFR Inhibition. Nat Cell Biol. 2014;16(5):457\u201368.","journal-title":"Nat Cell Biol"},{"issue":"4","key":"7865_CR13","doi-asserted-by":"publisher","first-page":"439","DOI":"10.6004\/jnccn.2021.0017","volume":"19","author":"MA Tempero","year":"2021","unstructured":"Tempero MA, Adenocarcinoma P, et al. Version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(4):439\u201357.","journal-title":"J Natl Compr Canc Netw"},{"key":"7865_CR14","doi-asserted-by":"publisher","first-page":"9693","DOI":"10.2147\/IJN.S226628","volume":"14","author":"CM Grapa","year":"2019","unstructured":"Grapa CM, et al. Epidermal growth factor receptor and its role in pancreatic cancer treatment mediated by nanoparticles. Int J Nanomed. 2019;14:9693\u2013706.","journal-title":"Int J Nanomed"},{"issue":"3","key":"7865_CR15","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1007\/s10637-010-9619-8","volume":"30","author":"D Strumberg","year":"2012","unstructured":"Strumberg D, et al. Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer. Invest New Drugs. 2012;30(3):1138\u201343.","journal-title":"Invest New Drugs"},{"issue":"6","key":"7865_CR16","doi-asserted-by":"publisher","first-page":"R287","DOI":"10.1530\/ERC-19-0058","volume":"26","author":"KA Schmohl","year":"2019","unstructured":"Schmohl KA, Nelson PJ, Spitzweg C. Tetrac as an anti-angiogenic agent in cancer. Endocr Relat Cancer. 2019;26(6):R287\u2013304.","journal-title":"Endocr Relat Cancer"},{"key":"7865_CR17","doi-asserted-by":"crossref","unstructured":"Huang CH et al. Combined treatment of heteronemin and tetrac induces antiproliferation in oral cancer cells. Mar Drugs. 2020;18(7).","DOI":"10.3390\/md18070348"},{"key":"7865_CR18","doi-asserted-by":"crossref","unstructured":"Unson S et al. Heteronemin and tetrac induce anti-proliferation by blocking EGFR-mediated signaling in colorectal cancer cells. Mar Drugs. 2022;20(8).","DOI":"10.3390\/md20080482"},{"issue":"3","key":"7865_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s12672-013-0137-y","volume":"4","author":"M Yalcin","year":"2013","unstructured":"Yalcin M, et al. Response of human pancreatic cancer cell xenografts to tetraiodothyroacetic acid nanoparticles. Horm Cancer. 2013;4(3):176\u201385.","journal-title":"Horm Cancer"},{"key":"7865_CR20","doi-asserted-by":"crossref","unstructured":"Huang TY et al. NDAT targets PI3K-Mediated PD-L1 upregulation to reduce proliferation in Gefitinib-Resistant colorectal cancer. Cells. 2020;9(8).","DOI":"10.3390\/cells9081830"},{"issue":"W1","key":"7865_CR21","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98\u2013102.","journal-title":"Nucleic Acids Res"},{"key":"7865_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"Chandrashekar DS, et al. An update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18\u201327.","journal-title":"Neoplasia"},{"issue":"3","key":"7865_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2217\/epi-2017-0118","volume":"10","author":"V Modhukur","year":"2018","unstructured":"Modhukur V, et al. MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data. Epigenomics. 2018;10(3):277\u201388.","journal-title":"Epigenomics"},{"issue":"D1","key":"7865_CR24","doi-asserted-by":"publisher","first-page":"D447","DOI":"10.1093\/nar\/gku1003","volume":"43","author":"D Szklarczyk","year":"2015","unstructured":"Szklarczyk D, et al. STRING v10: protein\u2013protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43(D1):D447\u201352.","journal-title":"Nucleic Acids Res"},{"issue":"21","key":"7865_CR25","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77(21):e108\u201310.","journal-title":"Cancer Res"},{"issue":"4","key":"7865_CR26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/path.2440","volume":"216","author":"F Pont\u00e9n","year":"2008","unstructured":"Pont\u00e9n F, Jirstr\u00f6m K, Uhlen M. The human protein Atlas\u2014a tool for pathology. J Pathology: J Pathological Soc Great Br Irel. 2008;216(4):387\u201393.","journal-title":"J Pathology: J Pathological Soc Great Br Irel"},{"key":"7865_CR27","unstructured":"Program CCS, et al. Nucleic Acids Res. 2025;53(D1):D886\u2013900. CZ CELLxGENE Discover: a single-cell data platform for scalable exploration, analysis and modeling of aggregated data."},{"issue":"43","key":"7865_CR28","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"7865_CR29","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, et al. ClusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov (Camb). 2021;2(3):100141.","journal-title":"Innov (Camb)"},{"issue":"269","key":"7865_CR30","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1\u20131.","journal-title":"Sci Signal"},{"issue":"24","key":"7865_CR31","doi-asserted-by":"publisher","first-page":"15576","DOI":"10.3390\/ijms232415576","volume":"23","author":"B Toledo","year":"2022","unstructured":"Toledo B, et al. Dual role of fibroblasts educated by tumour in cancer behavior and therapeutic perspectives. Int J Mol Sci. 2022;23(24):15576.","journal-title":"Int J Mol Sci"},{"key":"7865_CR32","doi-asserted-by":"crossref","unstructured":"Li Z-L et al. Integrin \u03b1v\u03b23-Targeted therapeutic strategies in pancreatic cancers. 2025.","DOI":"10.5772\/intechopen.1008947"},{"issue":"2Supplement","key":"7865_CR33","doi-asserted-by":"publisher","first-page":"B044","DOI":"10.1158\/1538-7445.PANCA2023-B044","volume":"84","author":"MP Dominguez","year":"2024","unstructured":"Dominguez MP, et al. Abstract B044: targeting integrin alpha V beta 3 remodels the tumor microenvironment in pancreatic cancer. Cancer Res. 2024;84(2Supplement):B044\u2013044.","journal-title":"Cancer Res"},{"issue":"6","key":"7865_CR34","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.devcel.2018.05.027","volume":"45","author":"NM Aiello","year":"2018","unstructured":"Aiello NM, et al. EMT subtype influences epithelial plasticity and mode of cell migration. Dev Cell. 2018;45(6):681\u201395. e4.","journal-title":"Dev Cell"},{"issue":"11","key":"7865_CR35","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.3390\/ijms20112767","volume":"20","author":"Y Hao","year":"2019","unstructured":"Hao Y, Baker D, Ten Dijke P. TGF-\u03b2-mediated epithelial-mesenchymal transition and cancer metastasis. Int J Mol Sci. 2019;20(11):2767.","journal-title":"Int J Mol Sci"},{"key":"7865_CR36","doi-asserted-by":"crossref","unstructured":"Vannini A et al. \u03b1v\u03b23-integrin regulates PD-L1 expression and is involved in cancer immune evasion. Proceedings of the national academy of sciences. 2019;116(40):20141\u201320150.","DOI":"10.1073\/pnas.1901931116"},{"issue":"4","key":"7865_CR37","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.tcb.2014.12.006","volume":"25","author":"L Seguin","year":"2015","unstructured":"Seguin L, et al. Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. Trends Cell Biol. 2015;25(4):234\u201340.","journal-title":"Trends Cell Biol"},{"key":"7865_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.canlet.2017.01.041","volume":"392","author":"H-x Zhan","year":"2017","unstructured":"Zhan H-x, et al. Crosstalk between stromal cells and cancer cells in pancreatic cancer: new insights into stromal biology. Cancer Lett. 2017;392:83\u201393.","journal-title":"Cancer Lett"},{"issue":"8","key":"7865_CR39","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.3390\/cells9081830","volume":"9","author":"T-Y Huang","year":"2020","unstructured":"Huang T-Y, et al. NDAT targets PI3K-mediated PD-L1 upregulation to reduce proliferation in gefitinib-resistant colorectal cancer. Cells. 2020;9(8):1830.","journal-title":"Cells"},{"issue":"15","key":"7865_CR40","doi-asserted-by":"publisher","first-page":"8553","DOI":"10.3390\/ijms25158553","volume":"25","author":"C Rodrigues Toledo","year":"2024","unstructured":"Rodrigues Toledo C, et al. EGFR-and integrin \u03b1V\u03b23-targeting peptides as potential radiometal-labeled radiopharmaceuticals for cancer theranostics. Int J Mol Sci. 2024;25(15):8553.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"7865_CR41","doi-asserted-by":"publisher","first-page":"BSR20181259","DOI":"10.1042\/BSR20181259","volume":"39","author":"F He","year":"2019","unstructured":"He F, et al. Reversal of EGFR inhibitors\u2019 resistance by co-delivering EGFR and integrin \u03b1v\u03b23 inhibitors with nanoparticles in non-small cell lung cancer. Biosci Rep. 2019;39(8):BSR20181259.","journal-title":"Biosci Rep"},{"issue":"2","key":"7865_CR42","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s10753-022-01770-6","volume":"46","author":"F Song","year":"2023","unstructured":"Song F, et al. Integrin \u03b1V\u03b23 signaling in the progression of osteoarthritis induced by excessive mechanical stress. Inflammation. 2023;46(2):739\u201351.","journal-title":"Inflammation"},{"issue":"3","key":"7865_CR43","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1083\/jcb.200205026","volume":"159","author":"BG G\u00e1lvez","year":"2002","unstructured":"G\u00e1lvez BG, et al. ECM regulates MT1-MMP localization with \u03b21 or \u03b1v\u03b23 integrins at distinct cell compartments modulating its internalization and activity on human endothelial cells. J Cell Biol. 2002;159(3):509\u201321.","journal-title":"J Cell Biol"},{"issue":"4","key":"7865_CR44","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1046\/j.1523-1747.2000.00114.x","volume":"115","author":"UB Hofmann","year":"2000","unstructured":"Hofmann UB, et al. Coexpression of integrin \u03b1v\u03b23 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: correlation with melanoma progression. J Invest Dermatology. 2000;115(4):625\u201332.","journal-title":"J Invest Dermatology"},{"issue":"1","key":"7865_CR45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/1097-0215(20000701)87:1<12::AID-IJC3>3.0.CO;2-A","volume":"87","author":"UB Hofmann","year":"2000","unstructured":"Hofmann UB, et al. Expression of integrin \u03b1v\u03b23 correlates with activation of membrane-type matrix metalloproteinase\u20101 (MT1\u2010MMP) and matrix metalloproteinase\u20102 (MMP\u20102) in human melanoma cells in vitro and in vivo. Int J Cancer. 2000;87(1):12\u20139.","journal-title":"Int J Cancer"},{"issue":"4","key":"7865_CR46","first-page":"5412","volume":"15","author":"B Pan","year":"2018","unstructured":"Pan B, et al. \u03b21 and \u03b23 integrins in breast, prostate and pancreatic cancer: A novel implication. Oncol Lett. 2018;15(4):5412\u20136.","journal-title":"Oncol Lett"},{"issue":"2","key":"7865_CR47","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1097\/00006676-200208000-00021","volume":"25","author":"R Hosotani","year":"2002","unstructured":"Hosotani R, et al. Expression of integrin alphaVbeta3 in pancreatic carcinoma: relation to MMP-2 activation and lymph node metastasis. Pancreas. 2002;25(2):e30\u20135.","journal-title":"Pancreas"},{"issue":"6","key":"7865_CR48","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.humpath.2005.03.014","volume":"36","author":"M Lim","year":"2005","unstructured":"Lim M, et al. \u03b1v\u03b23 integrin in central nervous system tumors. Hum Pathol. 2005;36(6):665\u20139.","journal-title":"Hum Pathol"},{"issue":"4","key":"7865_CR49","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s10120-014-0435-2","volume":"18","author":"C B\u00f6ger","year":"2015","unstructured":"B\u00f6ger C, et al. Integrins \u03b1v\u03b23 and \u03b1v\u03b25 as prognostic, diagnostic, and therapeutic targets in gastric cancer. Gastric Cancer. 2015;18(4):784\u201395.","journal-title":"Gastric Cancer"},{"issue":"1","key":"7865_CR50","doi-asserted-by":"publisher","first-page":"6994","DOI":"10.1038\/srep06994","volume":"4","author":"A Kim","year":"2014","unstructured":"Kim A, et al. Reduction of metastatic and angiogenic potency of malignant cancer by eupatorium Fortunei via suppression of MMP-9 activity and VEGF production. Sci Rep. 2014;4(1):6994.","journal-title":"Sci Rep"},{"issue":"9","key":"7865_CR51","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1007\/s10495-017-1392-0","volume":"22","author":"S de Mesquita","year":"2017","unstructured":"de Mesquita S. Acquisition of Anoikis resistance promotes alterations in the Ras\/ERK and PI3K\/Akt signaling pathways and matrix remodeling in endothelial cells. Apoptosis. 2017;22(9):1116\u201337.","journal-title":"Apoptosis"},{"issue":"4","key":"7865_CR52","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/carcin\/bgq024","volume":"31","author":"S Kim","year":"2010","unstructured":"Kim S, et al. TMPRSS4 induces invasion and epithelial\u2013mesenchymal transition through upregulation of integrin \u03b15 and its signaling pathways. Carcinogenesis. 2010;31(4):597\u2013606.","journal-title":"Carcinogenesis"},{"issue":"9","key":"7865_CR53","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1172\/JCI80011","volume":"125","author":"L Chen","year":"2015","unstructured":"Chen L, Han X. Anti-PD-1\/PD-L1 therapy of human cancer: past, present, and future. J Clin Invest. 2015;125(9):3384\u201391.","journal-title":"J Clin Invest"},{"key":"7865_CR54","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-med-092012-112807","volume":"65","author":"DB Page","year":"2014","unstructured":"Page DB, et al. Immune modulation in cancer with antibodies. Annu Rev Med. 2014;65:185\u2013202.","journal-title":"Annu Rev Med"},{"issue":"8","key":"7865_CR55","doi-asserted-by":"publisher","first-page":"e0136023","DOI":"10.1371\/journal.pone.0136023","volume":"10","author":"LH Schmidt","year":"2015","unstructured":"Schmidt LH, et al. PD-1 and PD-L1 expression in NSCLC indicate a favorable prognosis in defined subgroups. PLoS ONE. 2015;10(8):e0136023.","journal-title":"PLoS ONE"},{"issue":"5","key":"7865_CR56","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1530\/ERC-17-0376","volume":"25","author":"YT Chin","year":"2018","unstructured":"Chin YT, et al. Thyroxine inhibits resveratrol-caused apoptosis by PD-L1 in ovarian cancer cells. Endocr Relat Cancer. 2018;25(5):533\u201345.","journal-title":"Endocr Relat Cancer"},{"key":"7865_CR57","doi-asserted-by":"crossref","unstructured":"Su KW et al. Thyroid hormone induces oral cancer growth via the PD-L1-dependent signaling pathway. Cells. 2022;11(19).","DOI":"10.3390\/cells11193050"},{"issue":"4","key":"7865_CR58","doi-asserted-by":"publisher","first-page":"108339","DOI":"10.1016\/j.jbc.2025.108339","volume":"301","author":"SU Reddy","year":"2025","unstructured":"Reddy SU, et al. Immune checkpoint protein PD-L1 promotes transcription of angiogenic and oncogenic proteins IL-8, Bcl3, and STAT1 in ovarian cancer cells. J Biol Chem. 2025;301(4):108339.","journal-title":"J Biol Chem"},{"issue":"1","key":"7865_CR59","doi-asserted-by":"publisher","first-page":"12","DOI":"10.5483\/BMBRep.2021.54.1.241","volume":"54","author":"P Yadollahi","year":"2021","unstructured":"Yadollahi P, et al. Current Understanding of cancer-intrinsic PD-L1: regulation of expression and its protumoral activity. BMB Rep. 2021;54(1):12\u201320.","journal-title":"BMB Rep"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07865-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07865-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07865-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T14:03:56Z","timestamp":1772633036000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07865-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7865"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07865-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"321"}}